chr2-158115167-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_173355.4(UPP2):c.247G>A(p.Gly83Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_173355.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UPP2 | NM_173355.4 | c.247G>A | p.Gly83Arg | missense_variant | 3/7 | ENST00000005756.5 | |
UPP2 | NM_001135098.2 | c.418G>A | p.Gly140Arg | missense_variant | 5/9 | ||
UPP2 | XM_017003484.2 | c.247G>A | p.Gly83Arg | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UPP2 | ENST00000005756.5 | c.247G>A | p.Gly83Arg | missense_variant | 3/7 | 1 | NM_173355.4 | P1 | |
UPP2 | ENST00000605860.5 | c.418G>A | p.Gly140Arg | missense_variant | 6/10 | 5 | |||
UPP2 | ENST00000460456.1 | n.377-8582G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151978Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250802Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135526
GnomAD4 exome AF: 0.0000582 AC: 85AN: 1461602Hom.: 0 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 727084
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151978Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74222
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at